PhaseBio Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania, with additional operations in San Diego, California. The company focuses on the discovery and development of novel biopharmaceuticals for cardiovascular and other severe diseases.
Subscribe to see PhaseBio Pharmaceuticals Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PhaseBio Pharmaceuticals Inc is a biotechnology company headquartered in Malvern, United States. Its most recent funding round raised $26M in August 2018. Xcout tracks 15 named people at PhaseBio Pharmaceuticals Inc, including Jonathan Mow (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
9 more named people on record for PhaseBio Pharmaceuticals Inc, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $26M | — | |
| SEC Form D filing | $6.6M | — | |
| SEC Form D filing | $21M | — | |
| Series C | $40M | 5 named | |
| Series B | $25M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 7 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of PhaseBio Pharmaceuticals Inc's closest competitors — see the full list of competitors and alternatives →
Imbria Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel cardiovascular therapies.
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
XyloCor Therapeutics is a clinical-stage biopharmaceutical company headquartered in King of Prussia, Pennsylvania, focused on developing novel gene therapies for advanced coronary artery disease. The company is dedicated to improving patient outcomes through innovative cardiovascular treatments.
Ambros Therapeutics is a clinical-stage biotechnology company headquartered in Irvine, California, focused on the development of innovative therapeutics.
Bitterroot Bio is a privately held biotechnology company headquartered in Palo Alto, California, focused on the research and development of therapies for cardiovascular disease. The company operates as a biotechnology research firm and is engaged in clinical trials to evaluate its therapeutic pipeline.
VST Bio Corp. is a leader in the development of innovative biologics to treat acute and chronic cardiovascular diseases. Headquartered in San Diego, California, the company engages in drug pipelines, patents, and clinical trials.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about PhaseBio Pharmaceuticals Inc? Suggest a correction · Work at PhaseBio Pharmaceuticals Inc? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.